Nikhil Patkar

Nikhil Patkar

Advanced Centre for Treatment, Research & Education in Cancer - Maharashtra / India
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 432169
Tata Memorial Hospital
person_outline Nikhil Patkar's MOST POPULAR ARTICLES
1-) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms leukemia 36 (7), 1703-1719, 2022
2-) Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML) Leukemia 35 (5), 1392-1404, 2021
3-) A high‐sensitivity 10‐color flow cytometric minimal residual disease assay in B‐lymphoblastic leukemia/lymphoma can easily achieve the sensitivity of 2‐in‐106 and is superior … Cytometry Part B: Clinical Cytometry 98 (1), 57-67, 2020
4-) Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase … Cytometry Part B: Clinical Cytometry 94 (1), 100-111, 2018
5-) Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country Cytometry Part B: Clinical Cytometry 82 (4), 252-258, 2012